What's New on the FDA Drugs Site
September 15, 2015
- FDA Drug Safety Communication: FDA modifies monitoring for neutropenia associated with schizophrenia medicine clozapine; approves new shared REMS program for all clozapine medicines
- FDA Drug Safety Communication (Spanish): La FDA revisa la etiqueta del medicamento para diabetes canagliflozina (Invokana, Invokamet) para incluir actualizaciones sobre el riesgo de fracturas óseas y nueva información sobre la disminución de la densidad mineral ósea
- FDA Drug Shortages
- Levetiracetam (Keppra) Injection (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- Thiotepa (Thioplex) for Injection (New - Currently in Shortage)
.png)
No hay comentarios:
Publicar un comentario